It’s important for investors to know how to invest in penny stocks safely. That’s because they’re often volatile and can sometimes be fraudulent, despite offering triple-digit returns in a matter of weeks. We’ll show you our top two strategies for finding good penny stocks to buy, plus our small-cap stock pick primed for double-digit growth this year…
Video3 Strategies for Investing in Penny Stocks
If you’re looking for proof of just how explosively profitable penny stocks are, Delcath Systems Inc. (Nasdaq: DCTH) is a perfect piece of evidence. This company saw its stock price surge from $0.02 on June 1 to $0.19 on June 26. That marked a stunning 850% gain, which happened after the company announced phase 2 trial data for its cancer drug Melphalan would be released.
But these triple-digit returns aren’t always justified by the company’s profits or business potential. For instance, Chinese energy company Hongli Clean Energy Technologies Corp. (Nasdaq: CETC) saw shares jump 144% from $1.90 to $4.63 during just the first five sessions of April.
Top 10 Clean Energy Stocks To Watch Right Now: Omnicom Group Inc.(OMC)
- [By WWW.MONEYSHOW.COM]
We reprise five of last year’s components: Boeing (BA), CVS Health (CVS), International Business Machines (IBM), Omnicom Group (OMC) and Texas Instruments (TXN), which means they obviously are buys.
Top 10 Clean Energy Stocks To Watch Right Now: QuinStreet, Inc.(QNST)
- [By Dan Caplinger]
The mood was negative on Wall Street on Wednesday, and most major benchmarks finished in the red. Strength in the technology sector wasn’t enough to lift more cyclically focused benchmarks like the Dow Jones Industrial Average, and the combination of an attack on Saudi Arabia that sent oil prices higher and some disquieting readings on the inflation front kept investors from feeling more confident about stocks going into earnings season. In addition, some individual companies had bad news that sent their shares lower. Analogic (NASDAQ:ALOG), QuinStreet (NASDAQ:QNST), and MSC Industrial Direct (NYSE:MSM) were among the worst performers on the day. Here’s why they did so poorly.
Top 10 Clean Energy Stocks To Watch Right Now: Walker & Dunlop, Inc.(WD)
- [By Keith Speights]
Gilead Sciences (NASDAQ:GILD), Micron Technology (NASDAQ:MU), and Walker & Dunlop (NYSE:WD) actually have relatively low valuations. Here’s why these are three bargain stocks you can buy right now.
Top 10 Clean Energy Stocks To Watch Right Now: Biglari Holdings Inc.(BH)
- [By Lisa Levin]
Shares of Biglari Holdings Inc. (NYSE: BH) were down 20 percent to $339.00. Washington Prime Group Inc. (NYSE: WPG) will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
- [By Lisa Levin]
Check out these big penny stock gainers and losers
World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
Eleven Biotherapeutics, Inc. (NASDAQ: EBIO
- [By Lisa Levin]
Shares of Biglari Holdings Inc. (NYSE: BH) were down 17 percent to $352.05. Washington Prime Group Inc. (NYSE: WPG) will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
Top 10 Clean Energy Stocks To Watch Right Now: Acacia Communications, Inc. (ACIA)
- [By Peter Graham]
Small cap networking stock Acacia Communications (NASDAQ: ACIA) is the second most shorted stock on the Nasdaq with short interest of 54.23% according to Highshortinterest.com. Acacia Communications is a small cap developer, manufacturers and seller high-speed coherent optical interconnect products that are designed to transform communications networks through improvements in performance, capacity and cost. By leveraging silicon technology to build optical interconnects, a process Acacia Communications refers to as the siliconization of optical interconnect, the Company is able to offer products at higher speeds and density with lower power consumption, that meet the needs of cloud and service providers and can be easily integrated in a cost-effective manner with existing network equipment.
- [By ]
TheStreet’s founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Thursday’s trending stocks including Apple (AAPL) , Procter & Gamble (PG) , Nucor (NUC) and Acacia Communications (ACIA) .
- [By Scott Rubin]
Shares of Acacia Communications, Inc. (NASDAQ: ACIA) soared on the back of the company's second-quarter earnings results, closing the session up 41 percent to $95.67. Planet Fitness Inc (NYSE: PLNT) added 10 percent after reporting better-than expected results. The stock closed at $22.36. Steel stocks fell during Friday's session. United States Steel Corporation (NYSE: X) lost 7 percent to $21.06 and AK Steel Holding Corporation (NYSE: AKS) fell 6 percent to $5.03.
- [By ]
Investors always need to understand the risks of what they’re buying, Cramer reminded viewers, as he dug into the surprise, but totally foreseeable, 35% decline in shares of Acacia Communications (ACIA) on Monday.
- [By Evan Niu, CFA]
Shares of optical component companies have dropped today, includingOclaro (NASDAQ:OCLR), Acacia (NASDAQ:ACIA), Lumentum (NASDAQ:LITE), and Finisar (NASDAQ:FNSR), whose shares were down 11%, 11%, 6%, and 3%, respectively, as of 3:30 p.m. EDT, after the U.S. broadened its investigation regarding compliance with sanctions programs.
Top 10 Clean Energy Stocks To Watch Right Now: American Express Company(AXP)
- [By WWW.MONEYSHOW.COM]
American Express (AXP) has lagged it peers recently because its disciplined management team declined to enter a bidding war to keep its co-branding deals with Costco and Fidelity Investments.
- [By Paul Ausick]
American Express Co. (NYSE: AXP) traded up 0.43% at $99.56. The stock’s 52-week range is $73.50 to $100.53. Volume was less than half the daily average of around 3.25 million shares. The credit card company had no specific news.
- [By ]
“We’ve got over 100 banks using this,” said Ripple’s chief market strategist Cory Johnson, in an interview with TheStreet. “We’ve got companies like Bank of Santander, Standard Chartered and American Express (AXP) – banks all of the world are very active in using Ripple’s software to move money across borders.”
Top 10 Clean Energy Stocks To Watch Right Now: Theravance Biopharma, Inc.(TBPH)
- [By WWW.KIPLINGER.COM]
The exact date Theravance Biopharma Inc. (TBPH) intends to release a phase 3 update on COPD treatment Revefenacin isnt known. The company simply said in a prior communication with the market it would be sharing an interim look at the trials progress sometime in early Q4.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Theravance Biopharma (TBPH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 Clean Energy Stocks To Watch Right Now: Rayonier Advanced Materials Inc.(RYAM)
- [By Travis Hoium]
Shares of materials company Rayonier Advanced Materials Inc (NYSE:RYAM) jumped as much as 11.8% in trading Thursday after announcing a major acquisition. At 3:30 p.m. EDT, the shares were holding at a 10.6% gain on the day.
Top 10 Clean Energy Stocks To Watch Right Now: Regeneron Pharmaceuticals, Inc.(REGN)
- [By Johanna Bennett]
Shares of biotechnology giant Regeneron Pharmaceuticals (REGN) have climbed more than 4% today after Piper Jaffray analyst Ed Tenthoff upgraded the stock from a neutral to an overweight, with a $446 price target.
The upgrade comes just a few days after the drug maker released soft guidance for 2017 and forecasts called for slowing sales of the eye drug Eylea.
But Piper Jaffrays Tenthoff argues that anticipated approvals and deep pipeline should drive long-term value. Of particular importance: the atopic dermatitis drug Dupixent (dupilumab).
We are confident in FDA approval of Dupixent (dupilumab) in moderate-to-severe atopic dermatitis by the March 29th PDUFA date and in Europe in late 2017. The Phase III LIBERTY ASTHMA QUEST study has fully enrolled 1,858 persistent asthma patients to 200mg and 300mg subcu Dupixent q2W. We look for data this year to enable an sBLA submission by YE:17. Regeneron is conducting two Phase III trials in nasal polyps and will initiate Phase III pediatric atopic dermatitis and asthma trials. The company will report data from a Phase II eosinophilic esophagitis study in 1H:17 and begin a Phase II food allergy study in 2H:17. The FDA has deemed Sanofi’s Le Trait facility “acceptable”. As a result, we anticipate the partners will refile on Kevzara (sarilumab) and could gain approval in 2Q:17. These two launches should turn Regeneron’s antibody alliance with Sanofi profitable.
Todays news is the latest development in what has been a volatile time the drug maker. The shares have fallen sharply over the during the last three months, the result of a patent suit with Amgen (AMGN) over its anti-cholesterol drug Praluent, which a judge had set it wouldnt be able to sell in the U.S. , But last week, a judge granted a stay that would allow Regeneron to sell Praluent. It also fueled a pop in its shares.
The next day, however, Regeneron reported earnings, and while profits o
- [By Todd Campbell, Demitrios Kalogeropoulos, and Reuben Gregg Brewer]
In the case of these three stocks, however, it may be worth taking a gamble. Our contributors think catalysts at Regeneron Pharmaceuticals (NASDAQ:REGN), Royal Dutch Shell (NYSE:RDS-B), and United Parcel Service (NYSE:UPS) can get them back to their winning ways. Read on to find out if these down-and-out stocks are right for your portfolio.
- [By Chris Lange]
Shares of Amgen Inc. (NASDAQ: AMGN) saw a handy gain to close out the week after the company won a Delaware court ruling that blocked Sanofi (NYSE: SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) from selling their cholesterol-lowering drug in the United States. Essentially the court found that the drug Praluent actually infringed upon Amgens patents for its rival treatment Repatha.
- [By Ben Levisohn]
It hasn’t been an easy time for investors inRegeneron Pharmaceuticals (REGN) recently…and today’s price action is likely to reinforce the sense of whiplash they must be feeling.
Agence France-Presse/Getty Images
What do I mean? Regeneron’s dropped 14% during the last three months, the result of a patent suit with Amgen(AMGN) over its anti-cholesterol drug Praluent, which a judge had set it wouldn’t be able to sell in the U.S.Then last night, there was finally good news: Ajudge ordered a stay, which would allow Regeneron to sell Praluent, and resulted in a 2% pop in its shares last night after the market close. But then Regeneron reported earnings, and while profits of $3.04 cents a share metthe Street consensus, Regeneron missed on sales and offered disappointing guidance. That caused Regeneron shares to sink 2.1% in pre-open trading.
Fast forward to this afternoon, and and now they’re up nearly 3%. Credit Suisse analyst Alethia Young and team explain why the injunction outweighs the earnings:
Company issued Eylea guidance for 2017- they guided single digit
percentage growth over 2016. Consensus had been for 12% growth and we
had modeled 11% growth.
EPS for 4Q came in at $3.04 in line with $3.04 consensus. Since the company has already provided OpEx guidance for 2017 and the Eylea 4Q estimate ahead of today we think earnings are less of a focus.
We are curious where in the single digit percentage growth for Eylea the company means- 9% YoY growth wouldnt be too far from consensus vs. 3%
As we wrote last night, we would expect shares to trade up due to the injunction stay. We would expect shares to be up 2-4% from the injunction stay, but the effect might be muted somewhat by the Eylea guide. We would guess shares might be up 1 to 3% today.
Shares ofRegeneron Pharmaceuticals have gained 2.8% to $363.04 at 1:57 p.m. today, while the iS
Top 10 Clean Energy Stocks To Watch Right Now: Plantronics Inc.(PLT)
- [By Lisa Levin]
Shares of Plantronics Inc (NYSE: PLT) were down 25 percent to $33.36. Plantronics reported better-than-expected third-quarter earnings, but the company’s revenue missed analysts’ expectations. The company announced a new 1 million share buyback plan and issued a weak earnings forecast for the fourth quarter.
- [By Joseph Griffin]
TRADEMARK VIOLATION NOTICE: “Brian S. Dexheimer Sells 500 Shares of Plantronics (PLT) Stock” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at www.tickerreport.com/banking-finance/3355123/brian-s-dexheimer-sells-500-shares-of-plantronics-plt-stock.html.